Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Azithromycin mass drug administration to reduce childhood mortality in humanitarian crises.

PLOS global public health·2026

Same author

The risk of global Ebola virus spread is low: epidemiology of Ebola disease cases outside Africa, 1976 to May 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Same author

Barriers to and enablers of childhood immunization uptake in Ethiopia's Amhara, Oromia, and Somali Regions: A multi-perspective qualitative study.

PLOS global public health·2026

Same author

Sustained and indirect effects of PCV10 reduced-dose schedules on pneumococcal carriage in Viet Nam: a long-term follow-up of a cluster-randomised controlled trial.

The Lancet. Infectious diseases·2026

Same author

Epidemiological, immunological and virulence characteristics of persistent Streptococcus pneumoniae vaccine serotypes following vaccine introduction.

Nature communications·2026

Same author

Social contact patterns in the United Kingdom following the COVID-19 pandemic: The Reconnect cross-sectional survey.

PLoS medicine·2026

Search research articles

Related Experiment Video

Updated: Jan 18, 2026

Experimental Human Pneumococcal Carriage

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Pneumococcal conjugate vaccine use during humanitarian crises.

Kevin van Zandvoort¹, Francesco Checchi², Emma Diggle³

¹Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.

|September 29, 2019

Summary

Pneumococcal conjugate vaccines (PCVs) are crucial for reducing childhood mortality, especially during humanitarian crises. More research is needed to optimize PCV mass vaccination strategies in these challenging settings.

Keywords:

Humanitarian crises Humanitarian health Internally displaced people Pneumococcal conjugate vaccine Pneumonia Refugees Vaccination strategy

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Related Experiment Videos

Last Updated: Jan 18, 2026

Experimental Human Pneumococcal Carriage

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Area of Science:

Public Health
Vaccinology
Epidemiology

Background:

Streptococcus pneumoniae causes significant childhood mortality, particularly in low-income and crisis-affected regions.
Pneumococcal conjugate vaccines (PCVs) are effective but face uptake barriers during humanitarian crises.
Mass vaccination campaigns are a potential solution, but evidence for optimal strategies is lacking.

Purpose of the Study:

To address the paucity of evidence for structuring pneumococcal conjugate vaccine (PCV) mass vaccination campaigns in humanitarian crises.
To inform optimal vaccination strategies, including age targeting, dosing, and duration of impact, for PCV interventions in crisis settings.

Main Methods:

Proposing an evidence generation pathway combining primary data collection.
Utilizing mathematical modeling to analyze data and predict outcomes.
Conducting quasi-experimental evaluations of PCV interventions.

Main Results:

The study identifies a lack of evidence as a key hurdle for PCV use in humanitarian crises.
Reduced PCV pricing through the Humanitarian Mechanism makes addressing this gap critical.
The proposed pathway aims to generate data for evidence-based vaccination strategies.

Conclusions:

Optimizing PCV mass vaccination campaigns is essential for protecting vulnerable populations during humanitarian crises.
A structured evidence generation pathway is proposed to overcome research challenges in crisis settings.
Informing optimal vaccination strategies will enhance PCV impact and programmatic feasibility.